Today’s AI Top Pick: ADMA
8/26/2026 · Bullish Consensus Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live ADMA price forecast →
ADMA Biologics is the standout buy today because it pairs the strongest fundamentals in the pool with a forecast tape that is aggressively pointed up across near AND intermediate horizons. Fundamentals are exceptional: PE 13.8, fwdPe 10.3, PEG 0.46, ROE 41.9%, profit margin 32.98%, operating margin 42.26%, debt/equity 0.5, and analyst recom 1.33 with a 92.1% target upside — the highest quality/valuation combination in the entire candidate set. Sales growth is modest (8.04%) but margins and EPS growth (epsNextY 18.41%) are elite. The forecast stack is what makes this a today-trade, not a wait-trade. On the 4h it prints fc_short +59.02%, fc_mid +65.53%, fc_long +87.92% with pos_in_21bar_range 88.6% — hot, yes, but the 1d shows pos_in_range only 71.9% with fc_short +12.31 / fc_mid +35.48 / fc_long +49.33, and the 1wk sits at just 49.85% of range with a -14.65% drawdown from the weekly high — meaning you are NOT chasing an extended weekly move. That combination — strong short-term momentum with room to run on the weekly — is exactly the multi-timeframe geometry you want. Bullish_prob is 1.0 and near_term_bullish is 0.8. The landmine check: the Aug 5 Q2 miss did hit the stock (perfYtd -46.71%, perfYear -42.86%), but the more recent Aug 12 SeekingAlpha take ("The Earnings Reset Still Leaves More Upside") and Ascentiv +24% growth from the earnings call flip the narrative from disaster to reset. That's why the tape is now inflecting — the bad news is priced. Compare to OLLI, which just got a fresh guidance cut yesterday (disqualifying it as #1 despite a 1.0 near-term print), or CALX/PEGA which are sitting at 93–99% of their 21-bar range (pure chase). ADMA offers: bombed-out YTD, cheap on forward earnings, elite margins, strongest forecast magnitude in the group, and price NOT stretched on the higher timeframes. That's the trade today.
- Recent Q2 earnings miss (Aug 5) — any follow-through weakness in immunoglobulin pricing or Ascentiv ramp could re-trigger selling; the 1wk fc_short is -4.27% and fc_mid -8.57%, a real caution signal
- Small-cap biologic with 10.57% short float — squeeze potential upward but also elevated volatility and stop-hunt risk
- 1wk drawdown -14.65% and perfYear -42.86% mean the higher-timeframe trend is still repairing; a failed bounce would confirm continuation lower
- Concentration risk: single-product-family (IVIG/Ascentiv) revenue exposure to plasma supply and government reimbursement
- Sales growth decelerated to 8.04% YoY vs. prior double-digit prints — if the growth reset is structural, the multiple re-rate stalls
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | ADMA | BUY NOW | 9.1 | Elite fundamentals (PEG 0.46, PM 32.98%) + massive forecast magnitude (fc_long +87.92% 4h, +49.33% 1d) with weekly still at 49% of range = best asymmetric setup. |
| 2 | ISRG | BUY NOW | 8.4 | Cleanest multi-TF geometry: not extended anywhere, fc_short +40% (4h), bullish_prob 1.0, only risk is premium valuation. |
| 3 | CALX | BUY PULLBACK | 8.0 | Top fundamental score and near_term 0.8, but 94% pos_in_range on 4h/1d means wait for a $37 pullback. |
| 4 | KVYO | BUY PULLBACK | 7.6 | Near_term 1.0 and fc_mid +50% (4h), but PE 830 and 22.48% short float demand a better entry. |
| 5 | PDD | BUY PULLBACK | 7.4 | PE 9.73, PEG 0.7, fc_long +38.67% (4h), but at 100% of 4h range post-earnings — wait for the retest. |
| 6 | WAY | BUY NOW | 7.2 | Investor Day catalyst active, fundamental_score 8, recom 1.16, positive forecasts across all TFs, targetUpside 37%. |
| 7 | PEGA | BUY PULLBACK | 6.8 | Strong forecast (fc_short +46% 4h) and ROE 54.69 but pos_in_range 99.78% — pure chase risk. |
| 8 | ORCL | WAIT | 6.3 | VA contract positive but 1wk fc_short/mid/long all negative and near_term_bullish only 0.2 — trend deteriorating on higher TF. |
| 9 | TRI | BUY PULLBACK | 6.0 | Weekly at 95.81% of range with 4h fc_long -13.01% — extended, wait. |
| 10 | ETOR | WAIT | 5.8 | Bullish_prob null, RSI 43, two analyst PT cuts this week — mixed setup. |
| 11 | ALK | WAIT | 5.6 | Negative margins, forecasts positive but modest (fc_long +14% 1h), sector headline risk from ALGT. |
| 12 | DSGX | WAIT | 4.9 | Fresh Tai acquisition adds execution risk, 4h fc_mid -5.06%, bullish_prob 0.4. |
| 13 | QTWO | AVOID | 4.7 | Bullish_prob 0, 4h fc_short -3.43% at 92% of range — no edge. |
| 14 | OLLI | AVOID | 4.0 | Great forecast (fc_long +63% 4h) undercut by yesterday's guidance cut headline — landmine. |
| 15 | LRN | AVOID | 3.8 | SA downgrade on shaky enrollment, 4h forecasts all negative, 1wk fc_long -15.05%. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord